Sterol regulatory element-binding protein-1c and pancreatic β-cell dysfunction

Diabetes, Obesity and Metabolism

Volumn 9, Issue SUPPL. 2, 2007, Pages 133-139

  Shimano, Hitoshi ^a,c   Amemiya Kudo, M ^b   Takahashi, A ^a   Kato, T ^a   Ishikawa, M ^a   Yamada, N ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c NONE   (Japan)

Author keywords

Fatty acids; Insulin secretion; Lipotoxicity; Transcription factors

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN; GLUCOSE; GRANUPHILIN; ICOSAPENTAENOIC ACID; INSULIN RECEPTOR SUBSTRATE 2; ION CHANNEL; PALMITIC ACID; POLYUNSATURATED FATTY ACID; POTASSIUM; PROTEIN KINASE B; SATURATED FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

CONFERENCE PAPER; CYTOTOXICITY; DIABETES MELLITUS; DRUG MECHANISM; ENDOCRINE DISEASE; GENE ACTIVATION; INSULIN RELEASE; LIPOGENESIS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; UPREGULATION;

EID: 35148874217     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2007.00779.x     Document Type: Conference Paper

References (38)

1. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46: 3-19.
2. Steppel JH, Horton ES. Beta-cell failure in the pathogenesis of type 2 diabetes mellitus. Curr Diab Rep 2004; 4: 169-175.
3. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44: 863-870.
4. Shimano H, Yahagi N, Amemiya-Kudo M et al. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 1999; 274: 35832-35839.
5. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 1996; 98: 1575-1584.
6. Shimano H. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitam Horm 2002; 65: 167-194.
7. Shimano H. SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling. J Mol Med 2007; 85: 437-444.
8. Horton JD, Bashmakov Y, Shimomura I, Shimano H. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci U S A 1998; 95: 5987-5992.
9. Matsuzaka T, Shimano H, Yahagi N et al. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes 2004; 53: 560-569.
10. Lin J, Yang R, Tarr PT et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 2005; 120: 261-273.
11. Yahagi N, Shimano H, Hasty AH et al. A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J Biol Chem 1999; 274: 35840-35844.
12. Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS. Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J Biol Chem 2001; 276: 4365-4372.
13. Ou J, Tu H, Shan B et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci U S A 2001; 98: 6027-6032.
14. Yoshikawa T, Shimano H, Yahagi N et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 2002; 277: 1705-1711.
15. Sekiya M, Yahagi N, Matsuzaka T et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003; 38: 1529-1539.
16. Ide T, Shimano H, Yahagi N et al. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol 2004; 6: 351-357.
17. Horton JD, Shah NA, Warrington JA et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A 2003; 100: 12027-12032.
18. Inoue N, Shimano H, Nakakuki M et al. Lipid synthetic transcription factor SREBP-1a activates p21WAF1/CIP1, a universal cyclin-dependent kinase inhibitor. Mol Cell Biol 2005; 25: 8938-8947.
19. Medvedev AV, Robidoux J, Bai X et al. Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid. J Biol Chem 2002; 277: 42639-42644.
20. Wang H, Maechler P, Antinozzi PA et al. The transcription factor SREBP-1c is instrumental in the development of beta-cell dysfunction. J Biol Chem 2003; 278: 16622-16629.
21. Yamashita T, Eto K, Okazaki Y et al. Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a beta-cell lipotoxicity model overexpressing sterol regulatory element-binding protein-1c. Endocrinology 2004; 145: 3566-3577.
22. Takahashi A, Motomura K, Kato T et al. Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells. Diabetes 2005; 54: 492-499.
23. Howell SL. The mechanism of insulin secretion. Diabetologia 1984; 26: 319-327.
24. Prentki M, Tornheim K, Corkey BE. Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 1997; 40 (Suppl. 2): S32-S41.
25. Kato T, Shimano H, Yamamoto T et al. Granuphilin is activated by SREBP-1c and involved in impaired insulin secretion in diabetic mice. Cell Metab 2006; 4: 143-154.
26. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999; 96: 329-339.
27. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 2001; 108: 1631-1638.
28. Bernal-Mizrachi E, Fatrai S, Johnson JD et al. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 2004; 114: 928-936.
29. Lin X, Taguchi A, Park S et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 2004; 114: 908-916.
30. Yi Z, Yokota H, Torii S et al. The Rab27a/granuphilin complex regulates the exocytosis of insulin-containing dense-core granules. Mol Cell Biol 2002; 22: 1858-1867.
31. Gomi H, Mizutani S, Kasai K, Itohara S, Izumi T. Granuphilin molecularly docks insulin granules to the fusion machinery. J Cell Biol 2005; 171: 99-109.
32. Izumi T, Gomi H, Torii S. Functional analysis of Rab27a effector granuphilin in insulin exocytosis. Methods Enzymol 2005; 403: 216-229.
33. Kasai K, Ohara-Imaizumi M, Takahashi N et al. Rab27a mediates the tight docking of insulin granules onto the plasma membrane during glucose stimulation. J Clin Invest 2005; 115: 388-396.
34. Coppola T, Frantz C, Perret-Menoud V, Gattesco S, Hirling H, Regazzi R. Pancreatic beta-cell protein granuphilin binds Rab3 and Munc-18 and controls exocytosis. Mol Biol Cell 2002; 13: 1906-1915.
35. Torii S, Takeuchi T, Nagamatsu S, Izumi T. Rab27 effector granuphilin promotes the plasma membrane targeting of insulin granules via interaction with syntaxin 1a. J Biol Chem 2004; 279: 22532-22538.
36. Zhang CY, Baffy G, Perret P et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001; 105: 745-755.
37. Lameloise N, Muzzin P, Prentki M, Assimacopoulos-Jeannet F. Uncoupling protein 2: A possible link between fatty acid excess and impaired glucose-induced insulin secretion? Diabetes 2001; 50: 803-809.
38. Joseph JW, Koshkin V, Zhang CY et al. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 2002; 51: 3211-3219.